BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 12121301)

  • 1. Delayed sclerosis, neuroprotection, and limbic epileptogenesis after status epilepticus in the rat.
    Ebert U; Brandt C; Löscher W
    Epilepsia; 2002; 43 Suppl 5():86-95. PubMed ID: 12121301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy.
    Brandt C; Potschka H; Löscher W; Ebert U
    Neuroscience; 2003; 118(3):727-40. PubMed ID: 12710980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeic acid phenethyl ester prevents apoptotic cell death in the developing rat brain after pentylenetetrazole-induced status epilepticus.
    Yiş U; Topçu Y; Özbal S; Tuğyan K; Bayram E; Karakaya P; Yilmaz O; Kurul SH
    Epilepsy Behav; 2013 Nov; 29(2):275-80. PubMed ID: 24012504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term pregabalin treatment protects basal cortices and delays the occurrence of spontaneous seizures in the lithium-pilocarpine model in the rat.
    André V; Rigoulot MA; Koning E; Ferrandon A; Nehlig A
    Epilepsia; 2003 Jul; 44(7):893-903. PubMed ID: 12823571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged low-dose caffeine exposure protects against hippocampal damage but not against the occurrence of epilepsy in the lithium-pilocarpine model in the rat.
    Rigoulot MA; Leroy C; Koning E; Ferrandon A; Nehlig A
    Epilepsia; 2003 Apr; 44(4):529-35. PubMed ID: 12681001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of caspase 3 inhibitor during and after status epilepticus in rat: effect on neuronal damage and epileptogenesis.
    Narkilahti S; Nissinen J; Pitkänen A
    Neuropharmacology; 2003 Jun; 44(8):1068-88. PubMed ID: 12763100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent limbic seizures do not cause hippocampal neuronal loss: A prolonged laboratory study.
    Mathern GW; Bertram EH
    Neurobiol Dis; 2021 Jan; 148():105183. PubMed ID: 33207277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lesional and epileptogenic consequences of lithium-pilocarpine-induced status epilepticus are affected by previous exposure to isolated seizures: effects of amygdala kindling and maximal electroshocks.
    André V; Ferrandon A; Marescaux C; Nehlig A
    Neuroscience; 2000; 99(3):469-81. PubMed ID: 11029539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats.
    Brandt C; Gastens AM; Sun Mz; Hausknecht M; Löscher W
    Neuropharmacology; 2006 Sep; 51(4):789-804. PubMed ID: 16806297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epileptogenesis and neuropathology after different types of status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala in rats.
    Brandt C; Glien M; Potschka H; Volk H; Löscher W
    Epilepsy Res; 2003; 55(1-2):83-103. PubMed ID: 12948619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal damage after intra-amygdala kainic acid-induced status epilepticus and seizure preconditioning-mediated neuroprotection in SJL mice.
    Tanaka K; Jimenez-Mateos EM; Matsushima S; Taki W; Henshall DC
    Epilepsy Res; 2010 Feb; 88(2-3):151-61. PubMed ID: 19931419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus.
    Hu K; Xie YY; Zhang C; Ouyang DS; Long HY; Sun DN; Long LL; Feng L; Li Y; Xiao B
    BMC Neurosci; 2012 Sep; 13():115. PubMed ID: 22998082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance and hippocampal damage after delayed treatment of pilocarpine-induced epilepsy in the rat.
    Chakir A; Fabene PF; Ouazzani R; Bentivoglio M
    Brain Res Bull; 2006 Dec; 71(1-3):127-38. PubMed ID: 17113938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kynurenine pathway enzymes in a rat model of chronic epilepsy: immunohistochemical study of activated glial cells.
    Du F; Williamson J; Bertram E; Lothman E; Okuno E; Schwarcz R
    Neuroscience; 1993 Aug; 55(4):975-89. PubMed ID: 8232907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MK-801 sensitizes rats to pilocarpine induced limbic seizures and status epilepticus.
    Hughes P; Young D; Dragunow M
    Neuroreport; 1993 Mar; 4(3):314-6. PubMed ID: 8477054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA receptor activation during status epilepticus is required for the development of epilepsy.
    Rice AC; DeLorenzo RJ
    Brain Res; 1998 Jan; 782(1-2):240-7. PubMed ID: 9519269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of self-sustaining limbic status epilepticus by continuous ventral hippocampal stimulation followed by low dose pilocarpine in rats.
    George B; Mathur R; Kulkarni SK
    Indian J Physiol Pharmacol; 1998 Jul; 42(3):359-68. PubMed ID: 9741650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kainic acid-induced seizures produce necrotic, not apoptotic, neurons with internucleosomal DNA cleavage: implications for programmed cell death mechanisms.
    Fujikawa DG; Shinmei SS; Cai B
    Neuroscience; 2000; 98(1):41-53. PubMed ID: 10858610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats.
    Langer M; Brandt C; Zellinger C; Löscher W
    Neuropharmacology; 2011; 61(5-6):1033-47. PubMed ID: 21736883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilocarpine vs. lithium-pilocarpine for induction of status epilepticus in mice: development of spontaneous seizures, behavioral alterations and neuronal damage.
    Müller CJ; Bankstahl M; Gröticke I; Löscher W
    Eur J Pharmacol; 2009 Oct; 619(1-3):15-24. PubMed ID: 19632220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.